Literature DB >> 19184368

ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells.

Yi-Chang Cheng1, Wei-Wen Kuo, Hsi-Chin Wu, Tung-Yuan Lai, Chun-Hsien Wu, Jin-Ming Hwang, Wen-Hong Wang, Fuu-Jen Tsai, Jaw-Ji Yang, Chih-Yang Huang, Chun-Hsien Chu.   

Abstract

Leucine-zipper and sterile-alpha motif kinase (ZAK) is the key intra-cellular mediator protein in cardiomyocyte hypertrophy induction by transforming growth factor beta 1 (TGF-beta1) which has also been identified as a profibrotic cytokine involved in cardiac fibrosis progression. We hypothesized whether ZAK over-expression causes cardiac scar formation due to the extra-cellular matrix (ECM) degraded enzyme regulation in this paper. Using immuno-histochemical analysis of the human cardiovascular tissue array, we found a positively significant association between ZAK over-expression and myocardial scars. ZAK over-expression in H9c2 cardiomyoblast cells increases the metalloproteinase tissue inhibitor 1/2 (TIMP-1/2) protein level, which reduces matria metalloproteinase-9 (MMP-9) activity and also activates c-JNK N-terminal kinase 1/2 (JNK1/2) and p38 signaling, which induces MMP-2, possibly resulting in cardiac fibrosis. Taken together, ZAK activity inhibition may be a good strategy to prevent the cardiac fibrosis progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184368     DOI: 10.1007/s11010-008-0021-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.

Authors:  Jack P M Cleutjens; Esther E J M Creemers
Journal:  J Card Fail       Date:  2002-12       Impact factor: 5.712

Review 2.  Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.

Authors:  Davy Vanhoutte; Mark Schellings; Yigal Pinto; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2005-12-19       Impact factor: 10.787

3.  Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure.

Authors:  Karni S Moshal; Neetu Tyagi; Valerie Moss; Brooke Henderson; Mesia Steed; Alexander Ovechkin; Giorgio M Aru; Suresh C Tyagi
Journal:  J Cell Mol Med       Date:  2005 Jul-Sep       Impact factor: 5.310

Review 4.  Monitoring tissue repair and fibrosis from a distance.

Authors:  K T Weber
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

5.  Involvement of a p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia.

Authors:  K Mackay; D Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2000-08       Impact factor: 5.000

6.  Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes.

Authors:  Hiroki Aoki; Peter M Kang; James Hampe; Koichi Yoshimura; Takafumi Noma; Masunori Matsuzaki; Seigo Izumo
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

7.  Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.

Authors:  Stephane Heymans; Florea Lupu; Sven Terclavers; Bjorn Vanwetswinkel; Jean-Marc Herbert; Andrew Baker; Desire Collen; Peter Carmeliet; Lieve Moons
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

Review 8.  Mixed-lineage kinase control of JNK and p38 MAPK pathways.

Authors:  Kathleen A Gallo; Gary L Johnson
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

9.  Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase.

Authors:  Philipp Stawowy; Christian Margeta; Heike Kallisch; Nabil G Seidah; Michel Chrétien; Eckart Fleck; Kristof Graf
Journal:  Cardiovasc Res       Date:  2004-07-01       Impact factor: 10.787

Review 10.  TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.

Authors:  Meinhard Schiller; Delphine Javelaud; Alain Mauviel
Journal:  J Dermatol Sci       Date:  2004-08       Impact factor: 4.563

View more
  9 in total

1.  Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease.

Authors:  Samer Gawrieh; Tesfaye M Baye; Melanie Carless; James Wallace; Richard Komorowski; David E Kleiner; Deborah Andris; Bassem Makladi; Regina Cole; Michael Charlton; Joanne Curran; Thomas D Dyer; Jac Charlesworth; Russell Wilke; John Blangero; Ahmed H Kissebah; Michael Olivier
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.

Authors:  Rimsha Farooq; Khadim Hussain; Muhammad Tariq; Ali Farooq; Muhammad Mustafa
Journal:  J Appl Genet       Date:  2020-01-07       Impact factor: 3.240

4.  ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.

Authors:  You-Liang Hsieh; Ying-Lan Tsai; Marthandam Asokan Shibu; Chia-Chi Su; Li-Chin Chung; Peiying Pai; Chia-Hua Kuo; Yu-Lan Yeh; Vijaya Padma Viswanadha; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2015-04-14       Impact factor: 3.396

5.  BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.

Authors:  Harina Vin; Sandra S Ojeda; Grace Ching; Marco L Leung; Vida Chitsazzadeh; David W Dwyer; Charles H Adelmann; Monica Restrepo; Kristen N Richards; Larissa R Stewart; Lili Du; Scarlett B Ferguson; Deepavali Chakravarti; Karin Ehrenreiter; Manuela Baccarini; Rosamaria Ruggieri; Jonathan L Curry; Kevin B Kim; Ana M Ciurea; Madeleine Duvic; Victor G Prieto; Stephen E Ullrich; Kevin N Dalby; Elsa R Flores; Kenneth Y Tsai
Journal:  Elife       Date:  2013-11-05       Impact factor: 8.140

6.  Exome sequencing and CRISPR/Cas genome editing identify mutations of ZAK as a cause of limb defects in humans and mice.

Authors:  Malte Spielmann; Naseebullah Kakar; Naeimeh Tayebi; Catherine Leettola; Gudrun Nürnberg; Nadine Sowada; Darío G Lupiáñez; Izabela Harabula; Ricarda Flöttmann; Denise Horn; Wing Lee Chan; Lars Wittler; Rüstem Yilmaz; Janine Altmüller; Holger Thiele; Hans van Bokhoven; Charles E Schwartz; Peter Nürnberg; James U Bowie; Jamil Ahmad; Christian Kubisch; Stefan Mundlos; Guntram Borck
Journal:  Genome Res       Date:  2016-01-11       Impact factor: 9.043

7.  Pkcδ Activation is Involved in ROS-Mediated Mitochondrial Dysfunction and Apoptosis in Cardiomyocytes Exposed to Advanced Glycation End Products (Ages).

Authors:  Chih-Yang Huang; Wei-Wen Kuo; Yao-Chih Yang; Cheng-Yen Tsai; Chien-Lin Chen; Chia-Hua Kuo; Chien-Wen Hou; Shi-Yann Cheng; Ritu Aneja
Journal:  Aging Dis       Date:  2018-08-01       Impact factor: 6.745

Review 8.  The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications.

Authors:  Fatin Farhana Jubaidi; Satirah Zainalabidin; Izatus Shima Taib; Zariyantey Abdul Hamid; Nur Najmi Mohamad Anuar; Juriyati Jalil; Nor Anizah Mohd Nor; Siti Balkis Budin
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

9.  Moderate exercise training attenuates aging-induced cardiac inflammation, hypertrophy and fibrosis injuries of rat hearts.

Authors:  Po-Hsiang Liao; Dennis Jine-Yuan Hsieh; Chia-Hua Kuo; Cecilia-Hsuan Day; Chia-Yao Shen; Chao-Hung Lai; Ray-Jade Chen; V Vijaya Padma; Wei-Wen Kuo; Chih-Yang Huang
Journal:  Oncotarget       Date:  2015-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.